RxDoctor Payments Data

Kevin Macadaeg, MD

Pain Medicine · Carmel, INNPI 1114011681

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $267,498 of the $337,204 with a category attached, or 79.3%. Relievant Medsystems, Inc. accounts for 82.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $134,272 and has fallen 95.3% since, to $6,365 in 2025. Among pain medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$337,204in general payments, 2019–2025

Across 331 payments — averaging $1018.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Relievant Medsystems, Inc.$277K
  • Boston Scientific$47K
  • Ferring Pharmaceuticals Inc.$8K
  • Zimmer Biomet$5K
  • Vertos Medical, Inc.$377
  • Stryker$168
  • plus $275 from 4 others
$528,901in research payments, 2019–2025

Across 29 payments — averaging $18,238 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Relievant Medsystems, Inc.$343K
  • Seikagaku Corporation$185K

What the payments were for

  • Consulting fees$21,7706%
  • Speaking & faculty fees$267,49879%
  • Travel & lodging$31,7219%
  • Food & beverage$11,6073%
  • Education$4,6081%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$337,204 in reported general payments places this provider in the 95th percentile of 128 pain medicine providers in Indiana.

See all pain medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$254,508
Medicare patients
454
Services billed
5,110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib49$2,004
Gabapentin94$871
Methylprednisolone68$369
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$237
Tramadol Hcl29$125
Meloxicam17$49
Diazepam15$9

Paid to pharmacies, not to this prescriber.

Other pain medicine in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →